Published Date: 16 Feb 2023
Study documents huge financial costs of breast cancer treatment for women in high and low/middle income countries and offers opportunities for intervention.
Read Full NewsFormer UK prime minister Rishi Sunak has called for a targeted prostate cancer screening program for men most at high risk of the disease, reviving a national debate on how to save more lives and tackle health inequalities ...
In recent research, treatment with osimertinib plus a platinum–pemetrexed chemotherapy combination resulted in statistically significant and clinically meaningful improvement in overall survival in patients with newly diagnosed ...
About half of women over 40 have dense breasts. The denser the breast tissue, the more difficult it is to spot cancer on a standard mammogram. Having dense breast tissue can make it harder to detect cancer and sometimes leads ...
Researchers from Rutgers Health and other institutions have discovered why a powerful leukemia drug eventually fails in most patients—and found a potential way to overcome that resistance.
1.
According to JAMA, 5 alpha-reductase inhibitors are not significantly linked to prostate cancer mortality.
2.
An inhibitor of JAK1 exhibits "remarkable" activity in T-cell lymphoma.
3.
Hybrid imaging test combines antibody and radioisotope for early lung cancer detection
4.
AI catches one-third of interval breast cancers missed at screening
5.
Relationship-building key to addressing oncologist shortages in rural care
1.
Liquid Biopsy: Revolutionizing Precision Oncology in Hematological Malignancies
2.
A Visual Guide to Understanding Breast Cancer Staging
3.
Radiation Oncology: Integrating AI, Theranostics, and Adaptive Therapies for Personalized Cancer Care
4.
Neuroendocrine Tumors: Case Study on Diagnosis, Treatment Strategies & Patient Management
5.
Understanding Dasatinib: A Promising Drug for Cancer Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Efficient Management of First line ALK-rearranged NSCLC - Part IV
2.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II
4.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation